Fontaine G, Tonet J L, Frank R, Touzet I, Farenq G, Dubois-Rande J L, Baraka M, Abdelali S, Grosgogeat Y
Arch Mal Coeur Vaiss. 1986 Jul;79(8):1152-9.
Catheter ablation was used in 26 consecutive cases of high risk ventricular tachycardia (VT) resistant to antiarrhythmic therapy. Seven patients were in permanent VT at the time of catheter ablation, three of them were moribund. There were 10 cases of arrhythmogenic right ventricular dysplasia, 9 cases of VT complicating chronic myocardial infarction, 4 cases of dilated cardiomyopathy, 2 cases of idiopathic VT and one congenital cardiac malformation. Ten patients required 2 or more sessions of catheter ablation to treat their arrhythmia. Three of the 4 early deaths (less than 1 month) were due to technical problems. Combined with antiarrhythmic drugs in 8 cases, catheter ablation brought the VT under control in the 22 remaining patients. The follow-up period ranges from 10 to 28 months (average follow-up longer than 17 months). Catheter ablation is a technique which is currently under evaluation. The very encouraging results obtained in this series suggest that it may replace surgery in the treatment of chronic refractory VT.
对26例对抗心律失常治疗无效的高危室性心动过速（VT）患者连续进行了导管消融治疗。7例患者在进行导管消融时处于持续性室速状态，其中3例已奄奄一息。有10例致心律失常性右室发育不良，9例室速并发慢性心肌梗死，4例扩张型心肌病，2例特发性室速，1例先天性心脏畸形。10例患者需要进行2次或更多次导管消融治疗心律失常。4例早期死亡（不到1个月）中有3例是由于技术问题。8例患者联合使用了抗心律失常药物，导管消融使其余22例患者的室速得到控制。随访期为10至28个月（平均随访超过17个月）。导管消融是一项目前正在评估的技术。本系列取得的非常令人鼓舞的结果表明，它可能会取代手术治疗慢性难治性室速。
